Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prenatal Docosahexaenoic Acid (DHA) & Neurofunctional Development

NCT02709239 is registered in ClinicalTrials.gov with University of Kansas Medical Center as lead sponsor.

NCT NCT02709239
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02709239 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prenatal Docosahexaenoic Acid (DHA) & Neurofunctional Development
Lead sponsor
University of Kansas Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2016
Completion date
August 16, 2021
Enrollment
300 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

use and dose of prenatal dha supplementation